| Tori Brown Robinson, MD | |
|
3924 Minnesota Ave Ne, Washington, DC 20019-2661 | |
| (202) 398-8683 | |
| (202) 627-7815 |
| Full Name | Tori Brown Robinson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 3924 Minnesota Ave Ne, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477566677 | NPI | - | NPPES |
| 5732D988 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD037663 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Ardea Biosciences, Inc. announced that it will present results from a Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, at the 2009 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
AB SCIEX, a global leader in life science analytical technologies, and Phenomenex, a global leader in separation science techniques, today announced a new workflow solution specifically tailored for laboratories in India to ensure the safety of spices, teas, fruits, vegetables and other food products for domestic and export markets.
An interim report on a phase 2 clinical trial indicates both the safety and efficacy of a plant-produced virus-like particle vaccine candidate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine candidate has shown an acceptable safety profile and high potency in inducing humoral and cellular immune responses in adults (18 – 64 years) and elderly (65 years and above) individuals. The report is currently available on the medRxiv* preprint server.
The Fraxion head frame helps ensure accuracy and precision in stereotactic radiation therapy (SRT) of cancer targets in the brain and cranium. Elekta's Fraxion is the first to introduce an innovative system that integrates all proven cranial immobilization options in a single solution.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Ardea Biosciences, Inc. announced that it will present results from a Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, at the 2009 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
AB SCIEX, a global leader in life science analytical technologies, and Phenomenex, a global leader in separation science techniques, today announced a new workflow solution specifically tailored for laboratories in India to ensure the safety of spices, teas, fruits, vegetables and other food products for domestic and export markets.
An interim report on a phase 2 clinical trial indicates both the safety and efficacy of a plant-produced virus-like particle vaccine candidate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine candidate has shown an acceptable safety profile and high potency in inducing humoral and cellular immune responses in adults (18 – 64 years) and elderly (65 years and above) individuals. The report is currently available on the medRxiv* preprint server.
The Fraxion head frame helps ensure accuracy and precision in stereotactic radiation therapy (SRT) of cancer targets in the brain and cranium. Elekta's Fraxion is the first to introduce an innovative system that integrates all proven cranial immobilization options in a single solution.
› Verified 8 days ago
| Entity Name | Unity Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093894172 PECOS PAC ID: 3476647264 Enrollment ID: O20071024000456 |
News Archive
Ardea Biosciences, Inc. announced that it will present results from a Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, at the 2009 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
AB SCIEX, a global leader in life science analytical technologies, and Phenomenex, a global leader in separation science techniques, today announced a new workflow solution specifically tailored for laboratories in India to ensure the safety of spices, teas, fruits, vegetables and other food products for domestic and export markets.
An interim report on a phase 2 clinical trial indicates both the safety and efficacy of a plant-produced virus-like particle vaccine candidate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine candidate has shown an acceptable safety profile and high potency in inducing humoral and cellular immune responses in adults (18 – 64 years) and elderly (65 years and above) individuals. The report is currently available on the medRxiv* preprint server.
The Fraxion head frame helps ensure accuracy and precision in stereotactic radiation therapy (SRT) of cancer targets in the brain and cranium. Elekta's Fraxion is the first to introduce an innovative system that integrates all proven cranial immobilization options in a single solution.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tori Brown Robinson, MD 3924 Minnesota Ave Ne, Washington, DC 20019 Ph: (202) 627-7803 | Tori Brown Robinson, MD 3924 Minnesota Ave Ne, Washington, DC 20019-2661 Ph: (202) 398-8683 |
News Archive
Ardea Biosciences, Inc. announced that it will present results from a Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, at the 2009 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.
AB SCIEX, a global leader in life science analytical technologies, and Phenomenex, a global leader in separation science techniques, today announced a new workflow solution specifically tailored for laboratories in India to ensure the safety of spices, teas, fruits, vegetables and other food products for domestic and export markets.
An interim report on a phase 2 clinical trial indicates both the safety and efficacy of a plant-produced virus-like particle vaccine candidate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine candidate has shown an acceptable safety profile and high potency in inducing humoral and cellular immune responses in adults (18 – 64 years) and elderly (65 years and above) individuals. The report is currently available on the medRxiv* preprint server.
The Fraxion head frame helps ensure accuracy and precision in stereotactic radiation therapy (SRT) of cancer targets in the brain and cranium. Elekta's Fraxion is the first to introduce an innovative system that integrates all proven cranial immobilization options in a single solution.
› Verified 8 days ago
Dr. Ryan J. Montoya, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1225 4th St Ne, Washington, DC 20002 Phone: 202-763-7394 | |
Dr. Rufina Nwanneka Odigwe, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2139 Georgia Ave Nw, Suite 3b, Washington, DC 20001 Phone: 202-865-1452 | |
Miss Aruna Selina Harduarsingh-permaul, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3020 14th St Nw, Washington, DC 20009 Phone: 202-745-4300 | |
Dr. Jewel Bynoe Osborne-wu, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1050 Connecticut Ave Nw Ste 500, Washington, DC 20036 Phone: 202-596-8891 Fax: 833-941-2357 | |
Dr. Lori A. Spoor, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 Columbia Rd Nw, Washington, DC 20009 Phone: 202-469-4699 Fax: 813-254-0230 | |
Dr. Keith Michael Egan, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 2nd St Ne, Washington, DC 20002 Phone: 202-346-3000 | |
Richard A Elion, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 14th Street Nw, Second Floor, Washington, DC 20009 Phone: 202-745-6142 Fax: 202-745-6152 |